objectives polymorphisms promoter region gene shown interfere transcriptional activity gene resulting production different levels product suggesting involvement susceptibility severity inflammatory diseases set study consisting NUMBER copd chronic obstructive pulmonary disease NUMBER db bronchiectasis patients control groups NUMBER smokers smokers control group NUMBER general population subjects evaluate involvement gene polymorphisms abovementioned diseases homogeneous population methods novel methodology nanochip molecular biology workstation mbw nanogen employed genotype NUMBER promoter snps results conclusions genotype frequencies NUMBER snps showed significant difference copd db patient groups healthy smokers group statistical difference p0043 revealed haplotype frequencies copd patients compared general population control group nanochip mbw accurate method snp screening tnf alpha tnf alpha case control copd healthy tnf alpha http wwwnanogencom